BlackRock’s Genocea Biosciences, Inc. GNCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-180,367
Closed -$225K 5987
2022
Q1
$225K Sell
180,367
-5,076
-3% -$6.33K ﹤0.01% 4993
2021
Q4
$215K Buy
185,443
+4,452
+2% +$5.16K ﹤0.01% 5018
2021
Q3
$347K Buy
180,991
+2,019
+1% +$3.87K ﹤0.01% 4790
2021
Q2
$419K Buy
178,972
+35,685
+25% +$83.5K ﹤0.01% 4665
2021
Q1
$388K Buy
143,287
+6,028
+4% +$16.3K ﹤0.01% 4579
2020
Q4
$332K Buy
137,259
+2,192
+2% +$5.3K ﹤0.01% 4324
2020
Q3
$309K Sell
135,067
-59,994
-31% -$137K ﹤0.01% 4237
2020
Q2
$448K Buy
195,061
+45,261
+30% +$104K ﹤0.01% 4148
2020
Q1
$258K Sell
149,800
-2,726
-2% -$4.7K ﹤0.01% 4111
2019
Q4
$316K Buy
152,526
+67,757
+80% +$140K ﹤0.01% 4182
2019
Q3
$245K Buy
84,769
+46,755
+123% +$135K ﹤0.01% 4245
2019
Q2
$149K Buy
38,014
+13,018
+52% +$51K ﹤0.01% 4352
2019
Q1
$118K Buy
24,996
+116
+0.5% +$548 ﹤0.01% 4304
2018
Q4
$57K Buy
24,880
+144
+0.6% +$330 ﹤0.01% 4413
2018
Q3
$155K Sell
24,736
-5,532
-18% -$34.7K ﹤0.01% 4312
2018
Q2
$207K Sell
30,268
-464,776
-94% -$3.18M ﹤0.01% 4243
2018
Q1
$4.16M Buy
495,044
+311,067
+169% +$2.61M ﹤0.01% 3435
2017
Q4
$1.71M Buy
183,977
+1,477
+0.8% +$13.7K ﹤0.01% 3692
2017
Q3
$2.13M Buy
182,500
+3,278
+2% +$38.3K ﹤0.01% 3629
2017
Q2
$7.49M Buy
179,222
+143,126
+397% +$5.98M ﹤0.01% 3277
2017
Q1
$1.76M Buy
+36,096
New +$1.76M ﹤0.01% 3655
2016
Q2
Sell
-100
Closed -$6K 3805
2016
Q1
$6K Buy
100
+40
+67% +$2.4K ﹤0.01% 3301
2015
Q4
$3K Hold
60
﹤0.01% 3256
2015
Q3
$3K Hold
60
﹤0.01% 3113
2015
Q2
$7K Buy
+60
New +$7K ﹤0.01% 2978